{"id":229690,"date":"2020-10-28T09:04:10","date_gmt":"2020-10-28T13:04:10","guid":{"rendered":"https:\/\/oncubanews.com\/en\/?p=229690"},"modified":"2020-10-28T10:04:31","modified_gmt":"2020-10-28T14:04:31","slug":"cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials","status":"publish","type":"post","link":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/","title":{"rendered":"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials"},"content":{"rendered":"<p>The Cuban Soberana 02 <a href=\"https:\/\/oncubanews.com\/tag\/coronavirus\/\" target=\"_blank\" rel=\"noopener noreferrer\">COVID-19<\/a> vaccine candidate will soon begin its clinical trials in humans, after its approval by the island\u2019s regulatory body.<\/p>\n<p>The Finlay Vaccine Institute, the scientific entity in charge of its preparation, announced this Tuesday that the vaccine received approval from the Center for State Control of Medicines, Equipment and Medical Devices (CECMED) for the start of phase I clinical trials.<\/p>\n<p>\u201cWe are pleased to inform you that @CecmedCuba has approved the phase I clinical trial of the #Soberana02 vaccine candidate, based on a conjugate vaccine platform with a history in @FinlayInstituto. A know-how distinguishes us in the field of #preventive vaccines,\u201c the institution published on Twitter, although without specifying a possible date for the start of the tests.<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"500\" data-dnt=\"true\">\n<p lang=\"es\" dir=\"ltr\">Nos es grato informarles que se aprueba por <a href=\"https:\/\/twitter.com\/CecmedCuba?ref_src=twsrc%5Etfw\">@CecmedCuba<\/a> el ensayo cl\u00ednico fase I del candidato vacunal <a href=\"https:\/\/twitter.com\/hashtag\/Soberana02?src=hash&amp;ref_src=twsrc%5Etfw\">#Soberana02<\/a>, basado plataforma de vacunas conjugadas con antecedentes en <a href=\"https:\/\/twitter.com\/FinlayInstituto?ref_src=twsrc%5Etfw\">@FinlayInstituto<\/a>. Un saber hacer nos distingue en el campo de las <a href=\"https:\/\/twitter.com\/hashtag\/vacunas?src=hash&amp;ref_src=twsrc%5Etfw\">#vacunas<\/a> preventivas.<a href=\"https:\/\/twitter.com\/hashtag\/CienciaCubana?src=hash&amp;ref_src=twsrc%5Etfw\">#CienciaCubana<\/a> <a href=\"https:\/\/t.co\/xCTtHCLnYT\">pic.twitter.com\/xCTtHCLnYT<\/a><\/p>\n<p>&mdash; Instituto Finlay de Vacunas (@FinlayInstituto) <a href=\"https:\/\/twitter.com\/FinlayInstituto\/status\/1321122890775957504?ref_src=twsrc%5Etfw\">October 27, 2020<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>Days ago, Dr. Vicente V\u00e9rez, general director of the Finlay Institute, had advanced the imminent approval of this vaccine candidate, the <em>Agencia Cubana de Noticias<\/em> news agency <a href=\"http:\/\/www.acn.cu\/salud\/71860-aprueban-a-candidato-vacunal-cubano-soberana-02-para-fase-i-de-ensayos-clinicos\" target=\"_blank\" rel=\"noopener noreferrer\">recalled<\/a>, which explains that this vaccine, like Soberana 01, already in human trials, is a molecular or subunit product.<\/p>\n<p>However, following the specialist\u2019s explanations, the agency clarifies that Soberana 02 is \u201cthe only conjugate vaccine in the project against the pandemic,\u201d although it is not the first of its kind produced in Cuba, where there is \u201cextensive experience in the application of this type of preventive treatments.\u201d<\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"500\" data-dnt=\"true\">\n<p lang=\"es\" dir=\"ltr\">Les compartimos las diferencias entre <a href=\"https:\/\/twitter.com\/hashtag\/Soberana01?src=hash&amp;ref_src=twsrc%5Etfw\">#Soberana01<\/a> y <a href=\"https:\/\/twitter.com\/hashtag\/Soberana02?src=hash&amp;ref_src=twsrc%5Etfw\">#Soberana02<\/a>. <br \/>Ambas son <a href=\"https:\/\/twitter.com\/hashtag\/Vacunas?src=hash&amp;ref_src=twsrc%5Etfw\">#Vacunas<\/a> cubanas contra la <a href=\"https:\/\/twitter.com\/hashtag\/COVID19?src=hash&amp;ref_src=twsrc%5Etfw\">#COVID19<\/a>, con registros para ensayos cl\u00ednicos del <a href=\"https:\/\/twitter.com\/FinlayInstituto?ref_src=twsrc%5Etfw\">@FinlayInstituto<\/a> de <a href=\"https:\/\/twitter.com\/BioCubaFarma?ref_src=twsrc%5Etfw\">@BioCubaFarma<\/a>, con colaboraci\u00f3n de <a href=\"https:\/\/twitter.com\/centro_cim?ref_src=twsrc%5Etfw\">@centro_cim<\/a>, <a href=\"https:\/\/twitter.com\/UdeLaHabana?ref_src=twsrc%5Etfw\">@UdeLaHabana<\/a> y otros centros del sector. <a href=\"https:\/\/twitter.com\/hashtag\/CienciaCubana?src=hash&amp;ref_src=twsrc%5Etfw\">#CienciaCubana<\/a> <a href=\"https:\/\/t.co\/Jhp0wkgrJD\">pic.twitter.com\/Jhp0wkgrJD<\/a><\/p>\n<p>&mdash; Instituto Finlay de Vacunas (@FinlayInstituto) <a href=\"https:\/\/twitter.com\/FinlayInstituto\/status\/1321131664156905476?ref_src=twsrc%5Etfw\">October 27, 2020<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>According to Dr. V\u00e9rez, during the clinical trials of this vaccine candidate\u2015which has already been tested in animals\u2015\u201cit is expected that its safety will be demonstrated and that it will achieve a protective, powerful and long-lasting immune response, like Soberana 01, as well as verify what immunological properties are confirmed in vaccinated subjects,\u201d the source pointed out.<\/p>\n<p>In a recent exchange with Cuban President Miguel D\u00edaz-Canel, V\u00e9rez said that the team of Cuban scientists he heads \u201caspires to advance decisively in the studies regarding the immune response\u201d of Cuban vaccine candidates before the end of this year, with the aim of \u201cbeginning to vaccinate the Cuban population during the first semester of 2021.\u201d<\/p>\n<p>Regarding the safety of the drugs, he insisted that \u201cthey are based on vaccine technology platforms that already exist and have been tested in millions of doses.\u201d<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"FVk04Xd8jl\"><p><a href=\"https:\/\/oncubanews.com\/en\/cuba\/cuba-begins-clinical-trial-of-its-second-covid-19-vaccine-candidate\/\">Cuba begins clinical trial of its second COVID-19 vaccine candidate<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Cuba begins clinical trial of its second COVID-19 vaccine candidate&#8221; &#8212; OnCubaNews English\" src=\"https:\/\/oncubanews.com\/en\/cuba\/cuba-begins-clinical-trial-of-its-second-covid-19-vaccine-candidate\/embed\/#?secret=jWFk70SCU1#?secret=FVk04Xd8jl\" data-secret=\"FVk04Xd8jl\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p>Recently, the scientific institution had announced the start of a new clinical trial to evaluate different formulations and dose schedules of <a href=\"https:\/\/oncubanews.com\/cuba\/la-vacuna-cubana-soberana-01\/\" target=\"_blank\" rel=\"noopener noreferrer\">Soberana 01<\/a>. According to what has been explained, the study would carry out its phase I between October 19 and November 9, and its completion is scheduled for February 2021.<\/p>\n<p>Currently, Soberana 01 is in phases I and II of clinical trials with just over 700 volunteers. Its trial period has passed without adverse events, as reported so far.<\/p>\n<p>Created in 1991, the Finlay Vaccine Institute has recognized expertise in this field, and its most important achievements include the development of a vaccine against meningococcal meningitis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Cuban Soberana 02 COVID-19 vaccine candidate will soon begin its clinical trials in humans, after its approval by the island\u2019s regulatory body. The Finlay Vaccine Institute, the scientific entity in charge of its preparation, announced this Tuesday that the vaccine received approval from the Center for State Control of Medicines, Equipment and Medical Devices [&hellip;]<\/p>\n","protected":false},"author":3134,"featured_media":229691,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13902],"tags":[29532,32668,15273],"ppma_author":[33546,8689],"class_list":["post-229690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cuba","tag-coronavirus-in-cuba","tag-covid-19-vaccine","tag-cuban-science"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials | OnCubaNews English<\/title>\n<meta name=\"description\" content=\"Soberana 02 is \u201cthe only conjugate vaccine in the project against the pandemic,\u201d asexplained by specialists from the Finlay Vaccine Institute, the scientific institution in chargeof its development.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials | OnCubaNews English\" \/>\n<meta property=\"og:description\" content=\"Soberana 02 is \u201cthe only conjugate vaccine in the project against the pandemic,\u201d asexplained by specialists from the Finlay Vaccine Institute, the scientific institution in chargeof its development.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"OnCubaNews English\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-28T13:04:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-28T14:04:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/10\/Vacuna-Covid-19-Cuba-750x536-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"536\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"OnCuba Staff, OnCuba editorial staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"OnCuba Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/\"},\"author\":{\"name\":\"OnCuba Staff\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\"},\"headline\":\"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials\",\"datePublished\":\"2020-10-28T13:04:10+00:00\",\"dateModified\":\"2020-10-28T14:04:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/\"},\"wordCount\":533,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Vacuna-Covid-19-Cuba-750x536-1.jpg\",\"keywords\":[\"coronavirus in Cuba\",\"COVID-19 vaccine\",\"Cuban science\"],\"articleSection\":[\"Cuba\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/#respond\"]}],\"copyrightYear\":\"2020\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/\",\"name\":\"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials | OnCubaNews English\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Vacuna-Covid-19-Cuba-750x536-1.jpg\",\"datePublished\":\"2020-10-28T13:04:10+00:00\",\"dateModified\":\"2020-10-28T14:04:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\"},\"description\":\"Soberana 02 is \u201cthe only conjugate vaccine in the project against the pandemic,\u201d asexplained by specialists from the Finlay Vaccine Institute, the scientific institution in chargeof its development.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Vacuna-Covid-19-Cuba-750x536-1.jpg\",\"contentUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/Vacuna-Covid-19-Cuba-750x536-1.jpg\",\"width\":750,\"height\":536,\"caption\":\"Photo: @FinlayInstituto\\\/Twitter.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\",\"name\":\"OnCubaNews English\",\"description\":\"Revista sobre Cuba\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\",\"name\":\"OnCuba Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g17310096d4dde63ebae0e54fbb19218a\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g\",\"caption\":\"OnCuba Staff\"},\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/author\\\/oncuba-editorial-staff\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials | OnCubaNews English","description":"Soberana 02 is \u201cthe only conjugate vaccine in the project against the pandemic,\u201d asexplained by specialists from the Finlay Vaccine Institute, the scientific institution in chargeof its development.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials | OnCubaNews English","og_description":"Soberana 02 is \u201cthe only conjugate vaccine in the project against the pandemic,\u201d asexplained by specialists from the Finlay Vaccine Institute, the scientific institution in chargeof its development.","og_url":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/","og_site_name":"OnCubaNews English","article_published_time":"2020-10-28T13:04:10+00:00","article_modified_time":"2020-10-28T14:04:31+00:00","og_image":[{"width":750,"height":536,"url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/10\/Vacuna-Covid-19-Cuba-750x536-1.jpg","type":"image\/jpeg"}],"author":"OnCuba Staff, OnCuba editorial staff","twitter_card":"summary_large_image","twitter_misc":{"Written by":"OnCuba Staff","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/"},"author":{"name":"OnCuba Staff","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af"},"headline":"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials","datePublished":"2020-10-28T13:04:10+00:00","dateModified":"2020-10-28T14:04:31+00:00","mainEntityOfPage":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/"},"wordCount":533,"commentCount":0,"image":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/10\/Vacuna-Covid-19-Cuba-750x536-1.jpg","keywords":["coronavirus in Cuba","COVID-19 vaccine","Cuban science"],"articleSection":["Cuba"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/#respond"]}],"copyrightYear":"2020","copyrightHolder":{"@id":"https:\/\/oncubanews.com\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/","url":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/","name":"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials | OnCubaNews English","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/10\/Vacuna-Covid-19-Cuba-750x536-1.jpg","datePublished":"2020-10-28T13:04:10+00:00","dateModified":"2020-10-28T14:04:31+00:00","author":{"@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af"},"description":"Soberana 02 is \u201cthe only conjugate vaccine in the project against the pandemic,\u201d asexplained by specialists from the Finlay Vaccine Institute, the scientific institution in chargeof its development.","breadcrumb":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/#primaryimage","url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/10\/Vacuna-Covid-19-Cuba-750x536-1.jpg","contentUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2020\/10\/Vacuna-Covid-19-Cuba-750x536-1.jpg","width":750,"height":536,"caption":"Photo: @FinlayInstituto\/Twitter."},{"@type":"BreadcrumbList","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuban-sovereign-02-covid-19-vaccine-receives-approval-for-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oncubanews.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cuban Soberana 02 COVID-19 vaccine receives approval for clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/oncubanews.com\/en\/#website","url":"https:\/\/oncubanews.com\/en\/","name":"OnCubaNews English","description":"Revista sobre Cuba","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oncubanews.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af","name":"OnCuba Staff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g17310096d4dde63ebae0e54fbb19218a","url":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","caption":"OnCuba Staff"},"url":"https:\/\/oncubanews.com\/en\/author\/oncuba-editorial-staff\/"}]}},"authors":[{"term_id":33546,"user_id":3134,"is_guest":0,"slug":"oncuba-editorial-staff","display_name":"OnCuba Staff","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""},{"term_id":8689,"user_id":3134,"is_guest":0,"slug":"oncuba-editorial-staff","display_name":"OnCuba editorial staff","avatar_url":{"url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2018\/10\/avatar-ocnews-1.png","url2x":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2018\/10\/avatar-ocnews-1.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/229690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/users\/3134"}],"replies":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/comments?post=229690"}],"version-history":[{"count":0,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/229690\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media\/229691"}],"wp:attachment":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media?parent=229690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/categories?post=229690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/tags?post=229690"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/ppma_author?post=229690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}